Implantica appoints new experienced team to lead commercial operations
Retrieved on:
Friday, August 13, 2021
Lists of people executed in the United States, SIX Swiss Exchange, MBA, BBA, Doctor of Philosophy, KOL, Karl Storz SE, DACH, CEO, Obesity, Christianity and abortion, Biomedical engineering, Company, Marketing, International University, University, Boston Scientific, United Kingdom, Patient, Chief commercial officer, Medicine, Lloyds Bank Corporate Markets, Henric, Business School Lausanne, Johnson & Johnson, Hospital, Management
STOCKHOLM, Aug. 13, 2021 /PRNewswire/ -- Implantica AG (publ) today announces that a new team will be heading up the commercial operations at the Company including four highly experienced sales and marketing professionals, two of whom are joining in August 2021.
Key Points:
- STOCKHOLM, Aug. 13, 2021 /PRNewswire/ -- Implantica AG (publ) today announces that a new team will be heading up the commercial operations at the Company including four highly experienced sales and marketing professionals, two of whom are joining in August 2021.
- Stefan Vogt, the new Chief Commercial Officer, is responsible for the development and execution of commercialisation at Implantica.
- Henric Forsell is the VP Commercial Development at Implantica since 2018 and is responsible for developing and executing sales initiatives, market research and after-sales support.
- Stefan, Steffen and Gerhard bring a wealth of med-tech commercial strategy and sales infrastructure experience with a proactive approach and self-starter attitude.